Sarcopenia
Sarcopenia is a progressive skeletal muscle disorder characterized by loss of muscle mass, reduced muscle strength, and impaired physical performance.
Sarcopenia is a progressive skeletal muscle disorder characterized by loss of muscle mass, reduced muscle strength, and impaired physical performance. It is most commonly associated with aging, but it is also observed in chronic disease states such as cancer, type 2 diabetes mellitus, end-stage liver disease, chronic kidney disease, inflammatory disorders, and postoperative recovery settings. Clinically, sarcopenia is linked to frailty, disability, falls, poorer quality of life, increased treatment toxicity, and higher Mortality risk.
Biologically, sarcopenia is understood as a multifactorial condition involving chronic inflammation, nutritional imbalance, metabolic dysfunction, endocrine and immune dysregulation, altered muscle quality, and impaired muscle regeneration. Recent studies also suggest interactions with metabolic dysfunction-associated steatotic liver disease, metabolic dysfunction-associated steatohepatitis, oxidative stress, gut microbiota, and immunometabolic pathways. Because of its broad clinical impact and lack of universally effective pharmacotherapy, sarcopenia remains an active target for diagnostic, mechanistic, and interventional research.
Where the papers sit
12 papers from the last 6 months study sarcopenia directly · updated from PubMed 13 Nov 2026
Study type 3 clinical trials · 7 observational · 2 human data
Themes one subject · 1 paradigm shift
Those 12 are all about one subject.
-
Muscle Loss in Aging and Disease
Muscle loss is being treated as a cross-disease marker of vulnerability, spanning dialysis, cancer, ALS, kidney disease and older age. Low muscle mass or sarcopenia tracks with inflammation, malnutrition, treatment toxicity, infection risk and poorer survival, while links to urinary incontinence and brain-muscle function broaden the clinical picture. Machine-learning indices and digital gait measures are being explored for risk prediction, but their added value over standard assessment remains open. Exercise, electroacupuncture and online multicomponent programs offer early routes to improvement, without a unified treatment strategy yet.
In advanced cancer and diffuse large B-cell lymphoma, sarcopenia functions primarily as a marker of treatment vulnerability rather than disease-specific mortality
The advanced-cancer treatment study and the DLBCL immunochemotherapy study found that the established assumption that sarcopenia mainly reflects tumor-related prognosis is incomplete: sarcopenia was associated with severe treatment toxicity and mortality in older adults receiving cancer treatment 42782098Sep, while in DLBCL it predicted hematologic toxicity and nonrelapse mortality but not lymphoma-specific death 42664000Aug. The resulting shift is to interpret sarcopenia as a marker of host vulnerability and treatment tolerability, not simply as an indicator of cancer burden or cancer-specific progression.
Papers
The 12 papers from the last 6 months that study sarcopenia directly, newest first, by theme and by study type. Study types come from PubMed publication types and MeSH headings.
By theme
Muscle Loss in Aging and Disease (12)
- Sleep characteristics and sarcopenia in patients undergoing peritoneal dialysis: nonlinear associations and a potential adiposity-related pathway. Renal failure · 8 Nov 2026 PMID 43000169
- Prevalence and Overlap of Malnutrition, Sarcopenia and Related Nutritional Syndromes in a Large Haemodialysis Population. Journal of cachexia, sarcopenia and muscle · 29 Sept 2026 PMID 42806518
- Sarcopenic Obesity as a Key Determinant of Urinary Incontinence in Older Women. Geriatrics & gerontology international · 25 Sept 2026 PMID 42786931
- Sarcopenia Is Associated With Severe Treatment Toxicity and Mortality in Older Adults With Advanced Cancer: A Secondary Analysis. Journal of cachexia, sarcopenia and muscle · 24 Sept 2026 PMID 42782098
- Appendicular Skeletal Muscle Mass and Sarcopenia as Prognostic Markers in Amyotrophic Lateral Sclerosis. Journal of cachexia, sarcopenia and muscle · 10 Sept 2026 PMID 42717824
- A machine learning-derived sarcopenia index is associated with survival and nonrelapse mortality in DLBCL. Blood advances · 28 Aug 2026 PMID 42664000
- Association between sarcopenia and inflammation in non-geriatric patients with chronic kidney disease: a comparison of hemodialysis and non-hemodialysis patients. Journal of nephrology · 12 Aug 2026 PMID 42583874
- Sarcopenia is associated with poor survival among patients with non-metastatic renal cell carcinoma and venous tumor thrombus. World journal of urology · 6 Jul 2026 PMID 42406172
- Brain-Derived Neurotrophic Factor, Sarcopenia and Digital Gait Characteristics in Older Adults: Insights Into the Brain-Muscle Axis. Journal of cachexia, sarcopenia and muscle · 30 Jun 2026 PMID 42374879
- Predicting SIRS after PCNL using machine learning: the joint impact of sarcopenia and staghorn stones. World journal of urology · 25 Jun 2026 PMID 42347952
- The effects of electroacupuncture and the Otago Exercise Program in older adults with sarcopenia: A randomized controlled study. Medicine · 23 May 2026 PMID 42175481
- Multicomponent Online Intervention Improves Sarcopenia-Related Traits Following Long-Term Metabolic Bariatric Surgery: A Randomized Clinical Trial. Obesity surgery · 21 May 2026 PMID 42168690
By study type
Clinical trials (3)
- Sarcopenia Is Associated With Severe Treatment Toxicity and Mortality in Older Adults With Advanced Cancer: A Secondary Analysis. Journal of cachexia, sarcopenia and muscle · 24 Sept 2026 PMID 42782098
- The effects of electroacupuncture and the Otago Exercise Program in older adults with sarcopenia: A randomized controlled study. Medicine · 23 May 2026 PMID 42175481
- Multicomponent Online Intervention Improves Sarcopenia-Related Traits Following Long-Term Metabolic Bariatric Surgery: A Randomized Clinical Trial. Obesity surgery · 21 May 2026 PMID 42168690
Observational studies and case reports (7)
- Sleep characteristics and sarcopenia in patients undergoing peritoneal dialysis: nonlinear associations and a potential adiposity-related pathway. Renal failure · 8 Nov 2026 PMID 43000169
- Prevalence and Overlap of Malnutrition, Sarcopenia and Related Nutritional Syndromes in a Large Haemodialysis Population. Journal of cachexia, sarcopenia and muscle · 29 Sept 2026 PMID 42806518
- Sarcopenic Obesity as a Key Determinant of Urinary Incontinence in Older Women. Geriatrics & gerontology international · 25 Sept 2026 PMID 42786931
- Appendicular Skeletal Muscle Mass and Sarcopenia as Prognostic Markers in Amyotrophic Lateral Sclerosis. Journal of cachexia, sarcopenia and muscle · 10 Sept 2026 PMID 42717824
- Association between sarcopenia and inflammation in non-geriatric patients with chronic kidney disease: a comparison of hemodialysis and non-hemodialysis patients. Journal of nephrology · 12 Aug 2026 PMID 42583874
- Sarcopenia is associated with poor survival among patients with non-metastatic renal cell carcinoma and venous tumor thrombus. World journal of urology · 6 Jul 2026 PMID 42406172
- Predicting SIRS after PCNL using machine learning: the joint impact of sarcopenia and staghorn stones. World journal of urology · 25 Jun 2026 PMID 42347952
Human data, design not indexed (2)
- A machine learning-derived sarcopenia index is associated with survival and nonrelapse mortality in DLBCL. Blood advances · 28 Aug 2026 PMID 42664000
- Brain-Derived Neurotrophic Factor, Sarcopenia and Digital Gait Characteristics in Older Adults: Insights Into the Brain-Muscle Axis. Journal of cachexia, sarcopenia and muscle · 30 Jun 2026 PMID 42374879
Written from 12 PubMed abstracts, each one listed by PMID above. Published: 2026-06-26. Last written: 2026-08-27 by GPT. Drafted by language models from published abstracts; not medical advice.